Novartis extends operations at U.K. plant for another year,

Jun 9, 2021 11:21am
This marks the second time Novartis has decided to extend operations at its soon-to-be-shuttered Grimsby plant.
As Novartis shifts away from the production of older, less profitable drugs, the drugmaker has placed a slew of production facilities in the cost-cutting crosshairs. But with the company facing increased demand for two unnamed products, one plant is set to keep on churning through next year.
More than 200 Novartis manufacturing workers will keep their jobs for another year after the company unveiled plans to continue work at a soon-to-be-shuttered U.K. factory through the end of 2022, BusinessLive reports, quoting site head Ian Johnson. “These changes mean the majority of roles will be required longer,” he said.

Related Keywords

Ireland , Schweizerhalle , Switzerland General , Switzerland , Locarno , Ticino , Irish , Swiss , Brian Johnson , Novartis , Last May , Novartis Consumer Health , United Kingdom , Drug Manufacturing , Manufacturing Jobs , Job Cuts , Plant Closure , Pharma , Manufacturing , ஐயர்ல்யாஂட் , சுவிட்சர்லாந்து ஜநரல் , சுவிட்சர்லாந்து , லோகார்னோ , டிசினோ , ஐரிஷ் , சுவிஸ் , ஈயந் ஜான்சன் , நோவர்த்திச் , கடந்த இருக்கலாம் , நோவர்த்திச் நுகர்வோர் ஆரோக்கியம் , மருந்து உற்பத்தி , பார்மா ,